A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
NCT00171171
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
252
Enrollment
INDUSTRY
Sponsor class
Conditions
Beta-Thalassemia
Hemosiderosis
Interventions
DRUG:
deferasirox
Sponsor
Novartis